Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identifying genomic and developmental causes of adverse drug reactions in children.

Pharmacogenomics - 1 Nov 2010

Becker Mara L, Leeder J Steven

Abstract excerpt

Adverse drug reactions are a concern for all clinicians who utilize medications to treat adults and children; however, the frequency of adult and pediatric adverse drug reactions is likely to be under-reported. In this age of genomics and personalized medicine, identifying genetic variation that results in differences in drug biotransformation and response has contributed to significant advances in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Biotransformation
Share to Child

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug-Related Side Effects and Adverse Reactions

Share to Genomics

Share to Genotype

Share to Pharmaceutical Preparations

Share to Pharmacogenetics

Source

Open in PubMed Open full text

Identifiers

PMID: 21121777
DOI: 10.2217/pgs.10.146
PMCID: PMC3044438

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identifying genomic and developmental causes of adverse drug reactions in children.PMID 21121777Read ↗

Genotypic approaches to therapy in children: a national active surveillance network (GATC) to study the pharmacogenomics of severe adverse drug reactions in children.Semantic proximity Read ↗

Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives.Semantic proximity Read ↗

The role of pharmacogenomics in adverse drug reactionsSemantic proximity Read ↗

Digging up the human genome: current progress in deciphering adverse drug reactions.Semantic proximity Read ↗

The emerging era of pharmacogenomics: current successes, future potential, and challenges.Semantic proximity Read ↗

Advances in pharmacogenetics and pharmacogenomics.Semantic proximity Read ↗

Genomics of Adverse Drug Reactions.Semantic proximity Read ↗

Pharmacogenetics and adverse drug reactions.Semantic proximity Read ↗

Impact of New Genomic Technologies on Understanding Adverse Drug Reactions.Semantic proximity Read ↗

Individualizing the use of medications in children: making Goldilocks happy.Semantic proximity Read ↗

Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity.Semantic proximity Read ↗

Role of pharmacogenomics in the drug development.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.